JP2004516038A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516038A5 JP2004516038A5 JP2002553118A JP2002553118A JP2004516038A5 JP 2004516038 A5 JP2004516038 A5 JP 2004516038A5 JP 2002553118 A JP2002553118 A JP 2002553118A JP 2002553118 A JP2002553118 A JP 2002553118A JP 2004516038 A5 JP2004516038 A5 JP 2004516038A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- protein
- arl4
- dad1
- chronic inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25787800P | 2000-12-22 | 2000-12-22 | |
| PCT/EP2001/014838 WO2002052270A2 (en) | 2000-12-22 | 2001-12-15 | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516038A JP2004516038A (ja) | 2004-06-03 |
| JP2004516038A5 true JP2004516038A5 (https=) | 2005-04-21 |
Family
ID=22978162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002553118A Pending JP2004516038A (ja) | 2000-12-22 | 2001-12-15 | 慢性炎症性気道疾患の炎症性状態に陽性の影響を与える物質を同定するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20020150958A1 (https=) |
| EP (1) | EP1346228A2 (https=) |
| JP (1) | JP2004516038A (https=) |
| CA (1) | CA2430610A1 (https=) |
| MX (1) | MXPA03005325A (https=) |
| WO (1) | WO2002052270A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002256359A1 (en) * | 2001-04-24 | 2002-11-05 | Epigenesis Pharmaceuticals, Inc. | Antisense and anti-inflammatory based compositions to treat respiratory disorders |
| MXPA04001128A (es) * | 2001-08-06 | 2004-05-20 | Boehringer Ingelheim Pharma | Metodo para identificar sustancias que afectan realmente condiciones inflamatorias. |
| WO2004070058A1 (en) * | 2003-02-03 | 2004-08-19 | Bayer Healthcare Ag | Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of copd |
| US20070037156A1 (en) * | 2003-08-11 | 2007-02-15 | Lovelace Respiratory Research Institute | Metalloproteinase gene polymorphism in copd |
| WO2007044622A1 (en) | 2005-10-07 | 2007-04-19 | Yale University | Use of mif and mif pathway agonists |
| FR2904001A1 (fr) * | 2006-07-19 | 2008-01-25 | Galderma Res & Dev S N C Snc | Modulateurs de la udp-glucose ceramide glucosyltransferase dans le traitement de l'acne ou de l'hyperkeratinisation |
| CN104884955B (zh) * | 2012-12-07 | 2017-06-27 | 巴克斯特国际公司 | 抗‑mif抗体的细胞迁移测定方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645493B1 (en) * | 1993-05-17 | 2003-11-11 | The Picower Institute For Medical Research | Composition containing anti-MIF antibody |
| CA2389229A1 (en) * | 1999-10-29 | 2001-05-10 | The Picower Institute For Medical Research | Compounds having mif antagonist activity |
-
2001
- 2001-12-15 CA CA002430610A patent/CA2430610A1/en not_active Abandoned
- 2001-12-15 MX MXPA03005325A patent/MXPA03005325A/es unknown
- 2001-12-15 WO PCT/EP2001/014838 patent/WO2002052270A2/en not_active Ceased
- 2001-12-15 EP EP01988031A patent/EP1346228A2/en not_active Withdrawn
- 2001-12-15 JP JP2002553118A patent/JP2004516038A/ja active Pending
- 2001-12-21 US US10/029,654 patent/US20020150958A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bowdish | The aging lung: is lung health good health for older adults? | |
| Friedman | Hepatic fibrosis | |
| Niimi et al. | Nature of airway inflammation and remodeling in chronic cough | |
| Yang et al. | Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis | |
| Loukides et al. | Exhaled H2O2 in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease | |
| Miyaoka et al. | Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation | |
| PT1165110E (pt) | Antagonistas de hmg1 para tratamento de condicoes inflamatorias | |
| Mazzotta et al. | Different cytokine levels in thrombolysis patients as predictors for clinical outcome | |
| BRPI0518307A2 (pt) | mÉtodo e composiÇço de matÉria para tratar um indivÍduo tendo um cÂncer, kit, composiÇço farmacÊutica, mÉtodo para impregnar ou carregar um dispositivo implantÁvel de liberaÇço de droga, dispositivo implantÁvel de liberaÇço de droga, mÉtodo para avaliar a resposta de um indivÍduo tendo cÂncer a um tratamento usando um agonista de tlr3 ou selecionar um indivÍduo tendo um cÂncer que responde a um tratamento usando um agonista de tlr3, complexo, mÉtodo para determinar se um composto de teste É étil para o tratamento de cÂncer, e, uso de um agonista de tlr3 | |
| Fujita et al. | Serum C-reactive protein levels in postmortem blood—an analysis with special reference to the cause of death and survival time | |
| Zhang et al. | Tissue and BAL based biomarkers in asthma | |
| BRPI0408802B8 (pt) | método para a detecção de uma lesão de célula tubular renal isquêmica e método para identificar a extensão desta lesão | |
| RU2008145510A (ru) | Композиции и способы диагностики и лечения астмы или других аллергических или воспалительных заболеваний | |
| RU2009145695A (ru) | Способы выявления сердечных нарушений | |
| Molnár et al. | Assessment of heat provocation tests on the human gingiva: the effect of periodontal disease and smoking | |
| Johnson et al. | Airway smooth muscle and fibroblasts in the pathogenesis of asthma | |
| Kang et al. | Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion | |
| Stelmach et al. | Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis | |
| Ge et al. | Differential deposition of fibronectin by asthmatic bronchial epithelial cells | |
| JP2004516038A5 (https=) | ||
| Ebina | Pathognomonic remodeling of blood and lymphatic capillaries in idiopathic pulmonary fibrosis | |
| Song et al. | CTRP3 alleviates myocardial ischemia/reperfusion injury in mice through activating LAMP1/JIP2/JNK pathway | |
| Nakaya et al. | Noninvasive system for evaluating allergen-induced nasal hypersensitivity in murine allergic rhinitis | |
| Mitsunobu et al. | Enhanced production of leukotrienes by peripheral leukocytes and specific IgE antibodies in patients with chronic obstructive pulmonary disease | |
| RU2008116567A (ru) | Биомаркеры |